| Mrs Kirsten J Andrews, PA-C | |
|
7161 Lee Hwy Ste 400, Chattanooga, TN 37421-8604 | |
| (423) 708-8670 | |
| (423) 708-8671 |
| Full Name | Mrs Kirsten J Andrews |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant - Medical |
| Location | 7161 Lee Hwy Ste 400, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225575764 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | 3183 (Tennessee) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Kirsten J Andrews, PA-C 1360 Mackey Branch Dr, Chattanooga, TN 37421-3225 Ph: (423) 443-3336 | Mrs Kirsten J Andrews, PA-C 7161 Lee Hwy Ste 400, Chattanooga, TN 37421-8604 Ph: (423) 708-8670 |
News Archive
The findings, simultaneously published in the New England Journal of Medicine and presented at the American Society of Nephrology's Kidney Week 2020 conference, show the investigational drug finerenone had tangible renal and cardiovascular benefits for patients with chronic kidney disease and type 2 diabetes.
Texas Heart Institute has been selected as one of up to 60 sites in the world to participate in an international investigative study seeking to aid COVID-19 patients who develop acute respiratory distress syndrome (ARDS).
Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, announced today the selection of RG-125 (AZD4076), a GalNAc-conjugated anti-miR targeting microRNA-103/107 ("miR-103/107") for the treatment of Non Alcoholic Steatohepatitis ("NASH) in patients with type 2 diabetes/pre-diabetes, as a clinical candidate by AstraZeneca under the companies' strategic alliance to discover, develop and commercialize microRNA therapeutics.
Michigan State University and University of Nebraska Medical Center researchers are refuting an earlier French government-funded study that claims titanium dioxide, a common food additive used worldwide, causes digestive inflammation and lesions in rats.
Molecular technology developed by a University of Colorado at Boulder professor to probe extreme life forms in undersea hydrothermal vents has been used to identify unexpected bacteria strains in the lung fluid of Denver children suffering from cystic fibrosis, findings that may lead to more effective therapies.
› Verified 8 days ago
Ms. Brittany Cannon, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 979 E 3rd St Ste G, Chattanooga, TN 37403 Phone: 423-490-9080 Fax: 423-490-9076 | |
Scot M Hill, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1 Siskin Plz Ste 101, Chattanooga, TN 37403 Phone: 423-803-2226 Fax: 423-803-2222 | |
Linda M Mocniak, PC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1949 Gunbarrel Rd, Ste 160, Chattanooga, TN 37421 Phone: 423-664-4635 Fax: 423-664-4640 | |
Robert R Sciulli Jr., PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 281 N Lyerly St Ste 200, Chattanooga, TN 37404 Phone: 423-698-0850 Fax: 423-698-0511 | |
Kaitlin Sims, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1010 E 3rd St, Chattanooga, TN 37403 Phone: 423-265-2233 | |
Natalie Garcia, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 901 Riverfront Pkwy Ste 100, Chattanooga, TN 37402 Phone: 423-756-7134 | |
Ann Elizabeth Ripper, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2415 Mccallie Ave, Chattanooga, TN 37404 Phone: 423-624-2696 Fax: 423-624-1992 |